South. Magnesium (513498)

Score breakdown: P/E: 0/3 · ROCE: 2/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Reported ROCE of 31.16% suggests the existing capital base can earn a high operating return, if the ratio is genuine and recurring.
• Book value of ₹44.74 per share offers a tangible asset reference point for downside analysis.
• Latest quarter's net loss is negligible (-₹0 Cr), so the company is not currently burning large amounts of cash at this small scale.

Concerns

• Sales growth of -66.67% and latest quarter sales of only ₹1 Cr show a dramatic shrinkage in the business.
• No earnings exist; P/E is 0.00 and P/B is 5.52, meaning the market price is an enormous premium to book for a loss-making company.
• Piotroski F-Score of 3/9 indicates weak overall financial fundamentals.
• Promoter holding and debt/equity are N/A, leaving control and leverage risks unquantified.

AI Analysis

At ₹247, South Magnesium is a puzzle with no margin of safety. The market cap is ₹78 crore for a company that just reported only ₹1 crore of quarterly sales, a net loss of about nil, and a 66.67 per cent collapse in revenue. A value investor cannot underwrite a business whose profit growth is minus 111.43 per cent. The P/E is meaningless due to zero earnings, and paying 5.52 times book value of ₹44.74 means I am paying for hope, not facts. The reported ROCE of 31.16 per cent catches the eye, but it is inconsistent with a company losing money on tiny sales; if capital employed is truly generating that return, I would expect more than ₹1 crore of revenue. The Piotroski score of 3 out of 9 reinforces my suspicion: this is not a financially healthy firm. There is no dividend, promoter holding is not disclosed, and with D/E not available I cannot judge leverage. The price is at the upper end of a 52-week range of ₹61.15-₹247, a speculative re-rating unsupported by fundamentals. This is not a fast grower or a stalwart. It may be a cyclical minerals business at the bottom of its cycle, or a turnaround candidate, but the clean evidence of a turnaround is not in these numbers. I need to see quarterly sales recovery, positive margins, and a credible path to 10-15 per cent returns on equity at a sensible price. Until then, the disciplined play is to stay out. In Buffett's words, it is far better to lose an opportunity than to lose money. South Magnesium is a pass for now.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer